Chief Executive Officer
Devin has worked as a biologist and biochemist with NASA, built medical clinics in the jungles of the Congo, and pursued healthcare solutions as an entrepreneur, venture capitalist, and advisor. Devin is the CEO of Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee, builds and scales de novo companies, and provides oversight for 17 portfolio companies. Devin’s historical investments include AmericanWell (IPO), OneDrop (recapitalized by Bayer), Valify (acquired by HCA Healthcare), Trilliant Health (recapitalized by Primus Capital), Jvion (acquired by JMI Equity), Avizia (acquired by AmericanWell), Healthcare Bluebook (acquired by Primus Capital), and Clockwise.MD (acquired by DocuTAP).
Devin has founded several companies, including Reimagine Care, Wellvana, Trilliant Health, and Clariture Health.
- Reimagine Care is a home-centered oncology care company where he serves as Cofounder/Chairman of the board.
- Wellvana is a company that helps physician practices and healthcare systems move from fee-for-service to value-based care. He serves as Cofounder and Chairman of the Board, recently transitioning from the role of CEO. Devin helped start Wellvana in 2019, and the company has grown to supporting over 2,000 physician partners.
- Trilliant Health is a data science and analytics company, focused on helping healthcare systems build and execute growth strategies. Devin served as Cofounder and Chairman from its inception until the recapitalization with Primus Capital in 2019.
- Clariture Health is a digital marketing company helping healthcare systems increase patient acquisition. Devin served as Cofounder and CEO. During his tenure as CEO, the company increased revenue by 10x and delivered a 14x contribution margin return on marketing investment to his healthcare system clients.
Prior to Martin Ventures, Devin served as the corporate chief talent officer and chief strategy officer for Cancer Treatment Centers of America. He was part of the leadership team that increased employee engagement to the 93rd percentile, improved the patient experience to an NPS score of 96, and grew revenues to over $4.6 billion.
Prior to Cancer Treatment Centers of America, Devin was at Vanguard Health Systems, serving as the corporate chief experience officer and chief marketing officer. He was part of the leadership team that grew Vanguard to 29 hospitals, 46,000 employees, and $6.5 billion in revenue. Vanguard had a public offering in 2011 and sold to Tenet for $4.3 billion in 2013.
Prior to Vanguard Health Systems, Devin was in management consulting at Gallup. Devin was a Partner on the healthcare team. He was a trusted advisor to some leading healthcare systems (Cleveland Clinic, Henry Ford Health System, HCA, Tenet, Vanguard, etc.) on strategy, M&A, and organic growth.
Devin began his career as a scientist, biologist and biochemist with NASA. His research centered around the effects of vibration on bacterial growth and antibiotic resistance.
As a passion, Devin has served as a medical missionary in Congo, Africa, where he traveled through jungles building clinics to provide medical care in underserved villages.